That this House acknowledges the significant impact spondyloarthritis conditions have on individual sufferers and highlights the importance of achieving improved outcomes for patients; notes the often distressing and debilitating symptoms of the conditions, and the particular need to improve awareness of spondyloarthritis symptoms in light of the current eight and a half years average delay from onset spondyloarthritis to accurate diagnosis; recognises the fact that patients are more likely to experience a significantly lower quality of life and poorer employment outcomes compared with the wider population; and calls for all relevant stakeholders to work together to ensure effective implementation of NICE Guideline 65, Spondyloarthritis in over 16s: diagnosis and management and to support the ongoing development of a corresponding NICE Quality Standard for spondyloarthritis.